C4 Therapeutics
CCCC
CCCC
123 hedge funds and large institutions have $221M invested in C4 Therapeutics in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 41 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more funds holding
Funds holding: 101 → 123 (+22)
4.2% more ownership
Funds ownership: 82.39% → 86.59% (+4.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
123
Holding in Top 10
1
Calls
$1.02M
Puts
$352K
Top Buyers
| 1 | +$7.58M | |
| 2 | +$5.3M | |
| 3 | +$4.86M | |
| 4 |
Two Sigma Investments
New York
|
+$3.59M |
| 5 |
Goldman Sachs
New York
|
+$3.06M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$3.26M | |
| 3 | -$1.29M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.15M |
| 5 |
Walleye Capital
New York
|
-$481K |
